BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 33865343)

  • 1. Prediction of survival in amyotrophic lateral sclerosis: a nationwide, Danish cohort study.
    Kjældgaard AL; Pilely K; Olsen KS; Jessen AH; Lauritsen AØ; Pedersen SW; Svenstrup K; Karlsborg M; Thagesen H; Blaabjerg M; Theódórsdóttir Á; Elmo EG; Møller AT; Bonefeld L; Berg M; Garred P; Møller K
    BMC Neurol; 2021 Apr; 21(1):164. PubMed ID: 33865343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rate of disease progression: a prognostic biomarker in ALS.
    Labra J; Menon P; Byth K; Morrison S; Vucic S
    J Neurol Neurosurg Psychiatry; 2016 Jun; 87(6):628-32. PubMed ID: 26152368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Revised amyotrophic lateral sclerosis functional rating scale at time of diagnosis predicts survival time in amyotrophic lateral sclerosis].
    Liu XX; Fan DS; Zhang J; Zhang S; Zheng JY
    Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(35):2472-5. PubMed ID: 20137433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS.
    Kimura F; Fujimura C; Ishida S; Nakajima H; Furutama D; Uehara H; Shinoda K; Sugino M; Hanafusa T
    Neurology; 2006 Jan; 66(2):265-7. PubMed ID: 16434671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of spirometric tests in Amyotrophic Lateral Sclerosis patients.
    Pirola A; De Mattia E; Lizio A; Sannicolò G; Carraro E; Rao F; Sansone V; Lunetta C
    Clin Neurol Neurosurg; 2019 Sep; 184():105456. PubMed ID: 31382080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Categorization of the amyotrophic lateral sclerosis population via the clinical determinant of post-onset ΔFS for study design and medical practice.
    Ludolph AC; Corcia P; Desnuelle C; Heiman-Patterson T; Mora JS; Mansfield CD; Couratier P
    Muscle Nerve; 2024 Jul; 70(1):36-41. PubMed ID: 38712849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The amyotrophic lateral sclerosis functional rating scale predicts survival time in amyotrophic lateral sclerosis patients on invasive mechanical ventilation.
    Lo Coco D; Marchese S; La Bella V; Piccoli T; Lo Coco A
    Chest; 2007 Jul; 132(1):64-9. PubMed ID: 17475635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between depression and survival in Chinese amyotrophic lateral sclerosis patients.
    Wei Q; Zheng Z; Guo X; Ou R; Chen X; Huang R; Yang J; Shang H
    Neurol Sci; 2016 Apr; 37(4):557-63. PubMed ID: 26758858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting longitudinal functional decline and survival in amyotrophic lateral sclerosis patients.
    Watanabe H; Atsuta N; Nakamura R; Hirakawa A; Watanabe H; Ito M; Senda J; Katsuno M; Izumi Y; Morita M; Tomiyama H; Taniguchi A; Aiba I; Abe K; Mizoguchi K; Oda M; Kano O; Okamoto K; Kuwabara S; Hasegawa K; Imai T; Aoki M; Tsuji S; Nakano I; Kaji R; Sobue G
    Amyotroph Lateral Scler Frontotemporal Degener; 2015 Jun; 16(3-4):230-6. PubMed ID: 25548957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurophysiological indices in amyotrophic lateral sclerosis correlate with functional outcome measures, staging and disease progression.
    Barp A; Lizio A; Gerardi F; Tarlarini C; Mauro L; Sansone VA; Lunetta C
    Clin Neurophysiol; 2021 Jul; 132(7):1564-1571. PubMed ID: 34023632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of disease progression rate and related factors in amyotrophic lateral sclerosis patients at initial visit].
    Zhang JH; Wang HF; Yang F; He ZQ; Feng F; Li M; Bai JM; Wang HR; Huang XS
    Zhonghua Yi Xue Za Zhi; 2022 Jan; 102(3):222-227. PubMed ID: 35042292
    [No Abstract]   [Full Text] [Related]  

  • 12. ALSFRS-R score and its ratio: a useful predictor for ALS-progression.
    Kollewe K; Mauss U; Krampfl K; Petri S; Dengler R; Mohammadi B
    J Neurol Sci; 2008 Dec; 275(1-2):69-73. PubMed ID: 18721928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late-onset patients with sporadic amyotrophic lateral sclerosis in Japan have a higher progression rate of ALSFRS-R at the time of diagnosis.
    Tanaka Y; Yoshikura N; Harada N; Yamada M; Koumura A; Sakurai T; Hayashi Y; Kimura A; Hozumi I; Inuzuka T
    Intern Med; 2012; 51(6):579-84. PubMed ID: 22449665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of slow and forced vital capacities on ability to predict survival in ALS.
    Pinto S; de Carvalho M
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Nov; 18(7-8):528-533. PubMed ID: 28741375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the diagnosis delay and ALS functional impairment at diagnosis as relevant criteria for clinical trial enrolment.
    Hamidou B; Marin B; Lautrette G; Nicol M; Camu W; Corcia P; Arnes-Bes MC; Tranchant C; Clavelou P; Hannequin D; Maurice G; Beauvais K; Antoine JC; Danel-Brunaud V; Viader F; Preux PM; Couratier P
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Nov; 18(7-8):519-527. PubMed ID: 28762856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophils-to-Lymphocyte Ratio Is Associated with Progression and Overall Survival in Amyotrophic Lateral Sclerosis.
    Leone MA; Mandrioli J; Russo S; Cucovici A; Gianferrari G; Lisnic V; Muresanu DF; Giuliani F; Copetti M; The Pooled Resource Open-Access Als Clinical Trials Consortium ; Fontana A
    Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and neurophysiological biomarkers of disease progression in amyotrophic lateral sclerosis.
    Hannaford A; Byth K; Pavey N; Henderson RD; Mathers S; Needham M; Schultz D; Menon P; Kiernan MC; Vucic S
    Muscle Nerve; 2023 Jan; 67(1):17-24. PubMed ID: 36214183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Creatine for amyotrophic lateral sclerosis/motor neuron disease.
    Pastula DM; Moore DH; Bedlack RS
    Cochrane Database Syst Rev; 2010 Jun; (6):CD005225. PubMed ID: 20556761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity in ALSFRS-R decline and survival: a population-based study in Italy.
    Mandrioli J; Biguzzi S; Guidi C; Sette E; Terlizzi E; Ravasio A; Casmiro M; Salvi F; Liguori R; Rizzi R; Pietrini V; Borghi A; Rinaldi R; Fini N; Chierici E; Santangelo M; Granieri E; Mussuto V; De Pasqua S; Georgoulopoulou E; Fasano A; ; Ferro S; D'Alessandro R
    Neurol Sci; 2015 Dec; 36(12):2243-52. PubMed ID: 26205535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elimination Rate of Serum Lactate is Correlated with Amyotrophic Lateral Sclerosis Progression.
    Zhang YJ; Fan DS
    Chin Med J (Engl); 2016 Jan; 129(1):28-32. PubMed ID: 26712429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.